Mbah Anthony U, Ejim Emmanuel C, Onodugo Obinna D, Ezugwu Francis O, Eze Matthew I, Nkwo Peter O, Ugbajah Winston C
Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria.
BMC Res Notes. 2011 Jun 18;4:205. doi: 10.1186/1756-0500-4-205.
The mounting evidence linking hypothyroidism during pregnancy with poor pregnancy outcome underscores the need for screening and, therefore, a search for more reliable and cheaper screening methods.
The study was conducted in two phases. The phase one study comprised of healthy women in different stages of pregnancy who attended routine antenatal clinic at St Theresa's Maternity Hospital, Enugu, Nigeria from September 6 to October 18 1994. In this study the variables compared between the hypothyroid and non-hypothyroid pregnant women were maternal age, the number of the pregnancy or gravidity, gestational age, social class, body weight, height, the clinically assessed size of the thyroid gland, serum free thyroxin (FT4) and serum thyrotrophin (TSH). Based on the parameter differences between the two comparison groups of pregnant women two Logistic models, Model I and Model 11, were derived to differentiate the hypothyroid group from their non-hypothyroid counterparts. The two logistic models were then applied in a prospective validation study involving 197 pregnant women seen at presentation in Mother of Christ Specialist Hospital and Maternity, Ogui Road, Enugu from March 2002 to November 2007
The findings were that 82 (50.3%) of the 163 pregnant women had thyroid gland enlargement while 60 (36.8%) had hypothyroidism as defined by FT4 values below and/or TSH above their laboratory reference ranges. The pregnant subjects with hypothyroidism, compared with their non-hypothyroid counterparts, were characterized by a higher gravidity (p < 0.01), a higher body weight (p < 0.01), a higher goiter prevalence rate (p < 0.01) and a more advanced gestational age (p < 0.0001). A significant, positive correlation was also found between body weight and gestational age (r = 0.5; p < 0.01) At the cut-off point for Model l (fitted with gravidity, thyroid size and gestational age) it had a sensitivity of 100%, a specificity of 72.8% and an overall predictive accuracy of 82.9%; whereas for Model II (fitted with gravidity, thyroid size and body weight) the sensitivity was 100%, the specificity was 59.2% and the overall accuracy of discrimination was 74.8%. In the prospective validation study both models showed a sensitivity of 100% each with specificities of 85.5% for Model I and 76.2% for Model II.
It is concluded that logistic models fitting gravidity, thyroid gland size and gestational age or body weight are useful alternatives in screening for hypothyroidism during pregnancy. There is, however, a need for further independent confirmation of these findings.
越来越多的证据表明孕期甲状腺功能减退与不良妊娠结局相关,这凸显了筛查的必要性,因此需要寻找更可靠且更经济的筛查方法。
本研究分两个阶段进行。第一阶段研究纳入了1994年9月6日至10月18日期间在尼日利亚埃努古圣特雷莎妇产医院参加常规产前检查的处于不同孕期的健康女性。在该研究中,比较甲状腺功能减退和非甲状腺功能减退孕妇的变量包括产妇年龄、妊娠次数或孕次、孕周、社会阶层、体重、身高、临床评估的甲状腺大小、血清游离甲状腺素(FT4)和血清促甲状腺素(TSH)。基于两组孕妇比较参数的差异,推导了两个逻辑模型,模型I和模型II,以区分甲状腺功能减退组和非甲状腺功能减退组。然后将这两个逻辑模型应用于一项前瞻性验证研究,该研究涉及2002年3月至2007年11月在埃努古奥吉路基督之母专科医院和妇产医院就诊的197名孕妇。
结果显示,163名孕妇中有82名(50.3%)甲状腺肿大,60名(36.8%)甲状腺功能减退,其定义为FT4值低于和/或TSH高于实验室参考范围。与非甲状腺功能减退的孕妇相比,甲状腺功能减退的孕妇具有更高的孕次(p<0.01)、更高的体重(p<0.01)、更高的甲状腺肿患病率(p<0.01)和更晚的孕周(p<0.0001)。体重与孕周之间也发现了显著的正相关(r=0.5;p<0.01)。在模型I(拟合孕次、甲状腺大小和孕周)的截断点,其敏感性为100%,特异性为72.8%,总体预测准确率为82.9%;而对于模型II(拟合孕次、甲状腺大小和体重),敏感性为100%,特异性为59.2%,总体判别准确率为74.8%。在前瞻性验证研究中,两个模型的敏感性均为100%,模型I的特异性为85.5%,模型II的特异性为76.2%。
得出结论,拟合孕次、甲状腺大小和孕周或体重的逻辑模型是孕期筛查甲状腺功能减退的有用替代方法。然而,这些发现需要进一步独立验证。